We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$138M
AUM Growth
+$9.19M
Cap. Flow
+$1.05M
Cap. Flow %
0.76%
Top 10 Hldgs %
39.61%
Holding
87
New
4
Increased
12
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$1.57M
2
TTE icon
TotalEnergies
TTE
+$1.25M
3
PFE icon
Pfizer
PFE
+$1.19M
4
T icon
AT&T
T
+$1.06M
5
SLB icon
SLB Ltd
SLB
+$578K

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$634K
2
ABBV icon
AbbVie
ABBV
+$515K
3
AAPL icon
Apple
AAPL
+$502K
4
MSFT icon
Microsoft
MSFT
+$350K
5
CSX icon
CSX Corp
CSX
+$284K

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.81%
2 Healthcare 14.33%
3 Materials 12.87%
4 Technology 8.46%
5 Real Estate 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$349B
$19M 13.76%
152,386
-1,242
-0.8% -$152K
MSFT icon
2
Microsoft
MSFT
$2.93T
$6.22M 4.5%
39,440
-2,383
-6% -$350K
NEM icon
3
Newmont
NEM
$95.8B
$5.42M 3.92%
124,656
-2,328
-2% -$91K
ABBV icon
4
AbbVie
ABBV
$450B
$4.29M 3.1%
48,450
-6,200
-11% -$515K
MRK icon
5
Merck
MRK
$315B
$4.01M 2.9%
46,233
-2,796
-6% -$230K
CEF icon
6
Sprott Physical Gold and Silver Trust
CEF
$7.3B
$3.81M 2.75%
259,757
+17,410
+7% +$249K
FNV icon
7
Franco-Nevada
FNV
$38.7B
$3.2M 2.31%
30,950
+3,300
+12% +$319K
CSX icon
8
CSX Corp
CSX
$94.3B
$3.11M 2.25%
128,925
-12,000
-9% -$284K
MCHP icon
9
Microchip Technology
MCHP
$44B
$2.86M 2.07%
54,566
-3,300
-6% -$159K
DIS icon
10
Walt Disney
DIS
$170B
$2.84M 2.05%
19,625
-1,050
-5% -$147K
CLX icon
11
Clorox
CLX
$11.6B
$2.71M 1.96%
17,650
-1,000
-5% -$149K
PAAS icon
12
Pan American Silver
PAAS
$17.6B
$2.62M 1.9%
110,754
-515
-0.5% -$9.54K
CPRT icon
13
Copart
CPRT
$25.6B
$2.57M 1.86%
113,000
-4,600
-4% -$98.2K
TTE icon
14
TotalEnergies
TTE
$181B
$2.55M 1.84%
46,125
+23,675
+105% +$1.25M
PHYS icon
15
Sprott Physical Gold
PHYS
$14.4B
$2.54M 1.84%
208,427
-1,200
-0.6% -$14.3K
TGT icon
16
Target
TGT
$63.4B
$2.52M 1.82%
19,663
-1,675
-8% -$197K
T icon
17
AT&T
T
$152B
$2.41M 1.74%
81,508
+36,806
+82% +$1.06M
HE icon
18
Hawaiian Electric Industries
HE
$2.32B
$2.26M 1.63%
48,200
-1,200
-2% -$53.8K
WPM icon
19
Wheaton Precious Metals
WPM
$47.3B
$2.16M 1.56%
72,700
-1,500
-2% -$41K
AXP icon
20
American Express
AXP
$242B
$2.16M 1.56%
17,350
-450
-3% -$53.8K
PFE icon
21
Pfizer
PFE
$143B
$2.11M 1.52%
56,650
+33,383
+143% +$1.19M
ESS icon
22
Essex Property Trust
ESS
$18.8B
$2.06M 1.49%
6,853
-635
-8% -$201K
GRX
23
Gabelli Healthcare & Wellness Trust
GRX
$143M
$2M 1.44%
173,200
+35,700
+26% +$385K
SBUX icon
24
Starbucks
SBUX
$120B
$1.97M 1.43%
22,425
-2,450
-10% -$209K
PEP icon
25
PepsiCo
PEP
$187B
$1.87M 1.35%
13,658
-100
-0.7% -$13.6K

Similar funds

Bennicas & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Bennicas & Associates held 87 positions worth $138M, up 7.1% from $129M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Bennicas & Associates's Q4 2019 filing shows 4 new, 12 increased, 58 reduced and 2 closed positions. Its largest new stake was Occidental Petroleum: 39,257 shares worth $1.62M. The largest sale was ProShares Short S&P500, an estimated $634K.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Materials.

  • Bennicas & Associates's largest Q4 2019 buy was Occidental Petroleum: 39,257 shares worth $1.62M.
  • Bennicas & Associates added most to TotalEnergies in Q4 2019, an estimated $1.25M increase.
  • Bennicas & Associates's biggest Q4 2019 reduction was ProShares Short S&P500, cutting an estimated $634K.
  • Bennicas & Associates fully exited Diversified Healthcare Trust in Q4 2019, selling an estimated $183K.
  • Bennicas & Associates's ten largest holdings make up 40% of its $138M portfolio in Q4 2019.
  • Bennicas & Associates opened 4 new positions and closed 2 in Q4 2019.
  • Bennicas & Associates's portfolio value rose 7.1% quarter-over-quarter to $138M.

Based on Bennicas & Associates's 13F filing for Q4 2019, filed 17 Jan 2020.